Atria Investments Inc Has $9.32 Million Stock Position in McKesson Corporation $MCK

Atria Investments Inc reduced its holdings in shares of McKesson Corporation (NYSE:MCK) by 11.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,061 shares of the company’s stock after selling 1,555 shares during the quarter. Atria Investments Inc’s holdings in McKesson were worth $9,318,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in MCK. Solstein Capital LLC increased its stake in McKesson by 171.4% in the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company’s stock valued at $28,000 after buying an additional 24 shares during the last quarter. State of Wyoming bought a new position in shares of McKesson in the 2nd quarter valued at about $29,000. Hopwood Financial Services Inc. acquired a new stake in shares of McKesson in the third quarter valued at about $31,000. Delos Wealth Advisors LLC bought a new stake in McKesson during the second quarter worth about $35,000. Finally, Abound Wealth Management boosted its position in McKesson by 104.3% during the third quarter. Abound Wealth Management now owns 47 shares of the company’s stock valued at $37,000 after purchasing an additional 24 shares during the last quarter. Institutional investors own 85.07% of the company’s stock.

McKesson Price Performance

MCK stock opened at $916.08 on Friday. McKesson Corporation has a one year low of $585.22 and a one year high of $971.93. The stock has a market cap of $112.21 billion, a price-to-earnings ratio of 26.35, a price-to-earnings-growth ratio of 1.53 and a beta of 0.40. The company has a fifty day moving average price of $837.61 and a two-hundred day moving average price of $785.95.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter last year, the company posted $8.03 EPS. McKesson’s quarterly revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Research analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio is presently 9.43%.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Morgan Stanley reaffirmed an “overweight” rating and set a $966.00 price target on shares of McKesson in a research report on Thursday, January 29th. Barclays began coverage on shares of McKesson in a research note on Monday, December 8th. They issued an “overweight” rating and a $960.00 target price for the company. Mizuho upped their price target on shares of McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. TD Cowen increased their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Finally, UBS Group lifted their price objective on shares of McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $937.07.

Insider Buying and Selling

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the business’s stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the sale, the executive vice president directly owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their position. The SEC filing for this sale provides additional information. 0.08% of the stock is currently owned by company insiders.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.